ArticleOncogene2018
Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression.
Ke Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this papercites it